International Stem Cell Corporation logo

International Stem Cell Corporation (ISCO)

Market Closed
20 Jul, 20:00
OTCQX OTCQX
$
0. 20
+0.02
+11.1111%
$
1.71M Market Cap
- P/E Ratio
- Div Yield
4,100 Volume
0 Eps
$ 0.18
Previous Close
Add Transaction
Day Range
0.19 0.23
Year Range
0.12 0.23
Want to track ISCO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ISCO closed today higher at $0.2, an increase of 11.1111% from yesterday's close, completing a monthly increase of 17.6471% or $0.03. Over the past 12 months, ISCO stock gained 42.8571%.
ISCO is not paying dividends to its shareholders.
The last earnings report, released on Aug 14, 2025, exceeded the consensus estimates by 0.01%. On average, the company has fell short of earnings expectations by -0.0125%, based on the last three reports.
International Stem Cell Corporation has completed 1 stock splits, with the recent split occurring on Jul 29, 2015.
The company's stock is traded on one exchange.

ISCO Chart

International Stem Cell Corporation (ISCO) FAQ

What is the stock price today?

The current price is $0.20.

On which exchange is it traded?

International Stem Cell Corporation is listed on OTCQX.

What is its stock symbol?

The ticker symbol is ISCO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.71M.

Has International Stem Cell Corporation ever had a stock split?

International Stem Cell Corporation had 1 splits and the recent split was on Jul 29, 2015.

International Stem Cell Corporation Profile

Biotechnology Industry
Healthcare Sector
Andrey Semechkin CEO
OTCQX Exchange
460378201 CUSIP
US Country
33 Employees
- Last Dividend
29 Jul 2015 Last Split
- IPO Date

Overview

International Stem Cell Corporation is a clinical stage biotechnology firm that has laid its focus on the development of therapeutic and biomedical products across a global scale including the United States, Asia, and Europe. The company is known for its pioneering work in the field of regenerative medicine, especially with its neural stem cell program, ISC-hpNSC, which has reached completion in Phase I clinical trial targeting Parkinson's disease, and showing promising potential for applications in stroke and traumatic brain injury treatments. Founded in 2001, the company has its headquarters in San Diego, California, marking its presence as an influential player in the biotechnology and stem cell research industries.

Products and Services

  • ISC-hpNSC Neural Stem Cell Program

    This program is at the forefront of the company's initiatives, having completed a Phase I clinical trial for Parkinson's disease treatment, with prospects for extension into stroke and traumatic brain injury therapies.

  • Anti-aging Skin Care Products

    In addition to its medical therapies, the company also offers a line of anti-aging skin care products, which includes ProPlus Advanced Defense Complex, ProPlus Advanced Recovery Complex, Eye Firming Complex, Neck Firming Complex, Advanced Aqueous Treatment, Collagen Booster, Elastin Booster, and Brightening Toner specifically formulated to rejuvenate skin and delay signs of aging.

  • Human Cell Culture Products

    The company provides an extensive range of human cell culture products tailored for various research and medical purposes. This includes human skin cells for skin disease, toxicology, and wound healing studies; heart and blood vessel cells for cardiovascular disease and cancer research; bronchial and tracheal cell lines for toxicity, cystic fibrosis, asthma, and pathogenesis studies; mammary epithelial cell lines for breast cancer research; adult stem cells and reagents for regenerative medicine; prostate cells for prostate disease studies; renal and bladder cells for renal and bladder disease research; corneal cells for corneal disease studies; female reproductive system cells; skeletal muscle cells for a variety of biological and medical research purposes; and other vital cell culture reagents and supplements for the maintenance, growth, and analysis of these human cell cultures.

Contact Information

Address: 9745 Businesspark Avenue
Phone: 760 940 6383